Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer

Background: Bacillus Calmette-Guérin (BCG) immunotherapy is the standard-of-care adjuvant therapy for non-muscle-invasive bladder cancer in patients at considerable risk of disease recurrence. Although its exact mechanism of action is unknown, BCG significantly reduces this risk in responding patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowald, Saskia, Huge, Ylva, Tandiono, Decky, Ali, Zaheer, Vazquez-Rodriguez, Gabriela, Erkstam, Anna, Fahlgren, Anna, Sherif, Amir, Cao, Yihai, Jensen, Lasse D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914090/
https://www.ncbi.nlm.nih.gov/pubmed/36766850
http://dx.doi.org/10.3390/cells12030508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914090/
https://www.ncbi.nlm.nih.gov/pubmed/36766850
http://dx.doi.org/10.3390/cells12030508

Ejemplares similares